• Publications
  • Influence
Acute exacerbations of chronic bronchitis: a pharmacoeconomic review of antibacterial use.
TLDR
Current evidence suggests but does not prove that use of more effective but more costly first-line antibacterials may be relatively cost effective and may minimise overall expenditure by reducing the high costs associated with treatment failure.
New perspectives on parathyroid hormone therapy
TLDR
Combination and sequential therapy with parathyroid hormone offers new options to maximize efficacy in patients at risk for osteoporotic fracture.
Acute Exacerbations of Chronic Bronchitis
TLDR
Current evidence suggests but does not prove that use of more effective but more costly first-line antibacterials may be relatively cost effective and may minimise overall expenditure by reducing the high costs associated with treatment failure.
Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazine
TLDR
It is concluded that trifluoperazine can safely by given with bleomycin and that further study of the potential efficacy of this treatment is indicated.
Approval of Raxibacumab for the Treatment of Inhalation Anthrax Under the US Food and Drug Administration “Animal Rule”
TLDR
The developmental process required for approval of Raxibacumab illustrates many of the challenges that product developers may encounter when pursuing approval under the Animal Rule and highlights a number of important regulatory and policy issues.
The Use of Daptomycin to Treat Methicillin-Resistant Staphylococcus Epidermidis Bacteremia in a Critically Ill Child with Renal Failure.
TLDR
The case of an 8-year-old child with multiorgan failure undergoing continuous peritoneal dialysis, successfully treated with intravenous daptomycin for methicillin-resistant Staphylococcus epidermidis bacteremia is reported.
THE DEVELOPMENT OF A QUALITY IMPROVEMENT SYSTEM TO MONITOR, ASSESS AND FEEDBACK PRESCRIBING ERRORS IN PAEDIATRIC INTENSIVE CARE
TLDR
The aim of this project was to reduce prescribing errors by adapting a previous study that had developed a novel way of analysing, interpreting and publishing prescribing audit data to promote an educational approach to the authors' prescribing audits and provide constructive feedback and learning points for all prescribers on the unit.
O7 General pharmaceutical council revalidation: what is the best approach for conducting a peer discussion for paediatric pharmacists?
TLDR
Assessing whether a case based discussion between two experienced paediatric pharmacists will fulfil the GPhC requirements for revalidation has highlighted that peer discussion has the potential as a powerful tool for ensuring quality and improvement in paediatric pharmacy practice.
P38 An audit of antibiotic use in the treatment of neonatal necrotising enterocolitis (NEC): what do we use and how long for?
TLDR
This audit identified the type of antibiotics and the duration of therapy used to treat NEC within a single UK tertiary children’s hospital providing neonatal intensive care and neonatal surgery and found that patients were frequently not treated according to the local guideline.
...
1
2
3
...